Assessment of platelet activation in several different anticoagulants by the Advia 120 hematology system, fluorescence flow cytometry, and electron microscopy

Thrombosis and Haemostasis

Volumn 90, Issue 5, 2003, Pages 940-948

  Ahnadi, Charaf E ^a   Chapman, E Sabrinah ^b   Lépine, Mariette ^a   Okrongly, David ^b   Pujol Moix, Nuria ^c   Hernández, Angel ^c   Boughrassa, Faiza ^a   Grant, Andrew M ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b BAYER CORPORATION   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Activation; Advia 120; Anticoagulants; CD62P; Platelets

Indexed keywords

ADENOSINE; ANTICOAGULANT AGENT; CITRATE SODIUM; CITRATE THEOPHYLLINE DIPYRIDAMOLE ADENOSINE; EDETIC ACID; PADGEM PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING; CELL ISOLATION; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DRUG EFFECT; ELECTRON MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE; HEMATOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MEASUREMENT; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; VEIN PUNCTURE;

EID: 0242690425     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-02-0097     Document Type: Article

References (23)

1. George JN, Thio LL, Morgan RK. Quantitative analysis of platelet membrane glycoproteins: Effect of platelet washing procedures and isolation of platelet density subpopulations. Thromb Res 1981; 23: 69-77.
2. Hawiger J. Platelet secretory pathways: An overview. Methods Enzymol 1989; 169: 191-5.
3. Schmitz G, Rothe G, Ruf A, et al. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterization of platelet function. Thromb Haemost 1998; 79: 885-96.
4. National Committee for Clinical Laboratory Standards. Evacuated Tubes and Additives for Blood Specimen Collection. Approved Standard. NCCLS Document H1-A4 4th ed. NCCLS Villanova, PA; 1996.
5. Kühne T, Hornstein A, Semple J, et al. Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole. Am J Hematol 1995; 50: 40-5.
6. Golanski J, Pietrucha T, Baj Z, et al. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood - Various anticoagulants are not equal. Thromb Res 1996; 83: 199-216.
7. McCarthy DA, Macey MG. Novel anticoagulants for flow cytometric analysis of live leukocytes in whole blood. Cytometry 1996; 23: 196-204.
8. Ray MJ, Carroll PA, Just SJ, et al. A low volume container suitable for monitoring the aPTT of heparinized patients. Blood Coagul Fibrinolysis 1993; 4: 805-7.
9. Escolar G, White JG. Changes in glycoprotein expression after platelet activation: Differences between in vitro and in vivo studies. Thromb Haemost 2000; 83: 371-86.
10. Michelson AD. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: Methods and clinical applications. Blood Coagul Fibrinolysis 1994; 5: 121-31.
11. Chapman ES, Sorette M, Hetherington E, et al. A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination. Thromb Haemost 2003; 89: 1004-15.
12. Macey MG, Carty E, Webb L, et al. Use of mean platelet component to measure platelet activation on the Advia 120 haematology system. Cytometry 1999; 38: 250-5.
13. Pujol-Moix N, Hernández A, Escolar G, et al. Platelet ultrastructural morphometry for diagnosis of partial γ-storage pool disease in patients with mild platelet dysfunction and/or thrombocytopenia of unknown origin. Study of 24 cases. Haematologica 2000; 85: 620-7.
14. Kunicka JE, Fischer G, Murphy J, et al. Improved platelet counting using two-dimensional laser light scatter. Am J Clin Pathol 2000; 114: 283-9.
15. Corash L, Tan H, Gralnick H. Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume and ultrastructure. Blood 1977; 49: 71-87.
16. Mezzano D, Hwang K, Catalano P, et al. Evidence that platelet buoyant density, but not size, correlated with platelet age in man. Am J Hematol 1981; 11: 61-76.
17. Ruf A, Patscheke H. Flow cytometric detection of activated platelets: Comparison of determining shape change, fibrinogen binding, and P-selectin expression. Semin Thromb Hemost 1995; 21: 146-51.
18. White JG, Escolar G. EDTA-induced changes in platelet structure and function: Adhesion and spreading. Platelets 2000; 11: 56-61.
19. Neufeld M, Nowak-Gottl U, Junker R. Citrate-Theophylline-Adenosine-Dipyridamole buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurements of platelet activation. Clin Chem 1999; 45: 2030-3.
20. Mills DCB. The role of cyclic nucleotides in platelets. In: Cyclic Nucleotides Part II. Physiology and Pharmacology. Kebabian JW, Nathanson JA (eds) Berlin: Springer-Verlag 1982; 723-61.
21. Gresele P, Arnout J, Deckmyn H, et al. Mechanism of the anti-platelet action of dipyridamole in whole blood: Modulation of adenosine concentration and activity. Thromb Haemost 1986; 55: 12-17.
22. Feohtistov IA, Paul S, Hollister AS, et al. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation. Am J Hypertension 1992; 5: 147S-153S.
23. Michelson AD, Barnard MR, Krueger LA, et al. Evaluation of platelet function by flow cytometry. Methods 2000; 21: 259-70.